Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Cancer Remission: Time to Breathe Again

July 26th 2021

A survivor of prostate cancer celebrates the news that his cancer has not spread and describes how remission has made him feel.

Obese Patients Tend to Have Better Prostate Cancer Outcomes

July 20th 2021

Despite this “obesity paradox,” doctors do not recommend gaining weight with hopes of improving cancer outcomes.

‘Friends’ Actor James Michael Tyler Announces Prostate Cancer Diagnosis

June 21st 2021

The disease, which advanced to his spine and bones, prevented him from appearing onstage for the “Friends” reunion.

Better Prostate Cancer Screening for Younger African American Men May Improve Outcomes

June 16th 2021

Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Novel Therapy Appears Safe in Certain Patients with Prostate Cancer

June 7th 2021

The treatment was also associated with antitumor activity in patients with metastatic castration-resistant prostate cancer.

Certain Patients with Prostate Cancer Continue to Tolerate Extended Nubeqa Treatment

June 6th 2021

Patients with nonmetastatic castration-resistant prostate cancer continued to tolerate long-term treatment with Nubeqa, allowing them to maintain their quality of life and remain on therapy.

Men of African Ancestry Less Likely to Receive Genomic Profiling Early During Prostate Cancer Treatment

June 5th 2021

The data, according to one of the study’s authors, are critical in understanding the disparities in prostate cancer.

Investigational Therapy Significantly Improves Survival in Patients with Prostate Cancer

June 4th 2021

The addition of an investigational therapy to standard-of-care treatment was associated with a median overall survival of 15.3 months in patients with progressive PSMA-positive metastatic castration-resistant prostate cancer.

FDA Approves First PET Imaging Agent to Identify Prostate Cancer Metastasis or Recurrence

May 27th 2021

The PET imaging agent targets prostate-specific membrane antigen levels, which can improve the detection of suspected disease spread or recurrence compared with standard approaches.

Increased Screening Associated with Improved Outcomes in Younger Black Patients with Prostate Cancer

May 21st 2021

The study results lend strength to discuss prostate cancer screening in younger Black men, according to an expert.

'The Today Show' Anchor Al Roker Shares He Almost Delayed the Physical That Led to A Prostate Cancer Diagnosis, 'The Heartbreak Kid' Actor Charles Grodin Dies from Cancer, And More

May 21st 2021

From Al Roker’s cancer screening advice to the death of actor Charles Grodin, here’s what’s happening in the cancer landscape this week.

A Prostate Cancer Researcher’s Unique Perspective as A Cancer Survivor

May 6th 2021

In this episode of the “CURE® Talks Cancer” podcast, Leanne Burnham, Ph.D., discusses the research she’s working on to address health disparities in Black men with prostate cancer after being inspired by her father’s diagnosis, and shares her own cancer survival story.

Veterans with Prostate Cancer Are Underassessed And Undertreated For Cardiovascular Risk Factors

April 28th 2021

A recent analysis of veterans with prostate cancer showed that they are not being assessed and treated for cardiovascular risk factors at the rate they should be to optimize survival, particularly when being treated with androgen deprivation therapy, which has been associated with increased risk for cardiovascular disease.

‘Fun’ and ‘Cancer’ Can Go Together

March 28th 2021

A prostate cancer survivor recalls a time when the cancer center’s staff helped him realize that its OK to have fun while receiving cancer treatment.

5 Things You Should Never Say to Someone with Cancer

March 14th 2021

Never say to someone that at least they have a “good” kind of cancer or that they don’t really look that sick, writes one cancer survivor.

Approval of Orgovyx ‘Extremely Significant’ for Patients with Advanced Prostate Cancer

March 11th 2021

The Food and Drug Administration’s recent approval of the first oral hormone therapy, Orgovyx, for the treatment of advanced prostate cancer has positioned the drug to become a standard of care for patients, according to an expert.

The Problem With the Phrase ‘Cancer-Free’

March 7th 2021

A survivor takes a closer look at the trouble with using the phrase “cancer-free” when discussing the disease with friends and family.

CURE’s Clinical Trial Corner: February 2021

February 25th 2021

Here is a list of some recent trials that launched within the cancer space in February.

A Cancer Survivor Embraces a New Career as a ‘Sit-Down Comedian’

February 21st 2021

“Did you hear the one about the cancer procedure that went terribly wrong?” “It turned out to be a ‘bi-oopsie!’”

Zytiga and Prednisone Plus Erleada Reduces Risk of Disease Progression in Prostate Cancer Subtype

February 12th 2021

The combination of Erleada, Zytiga and the steroid prednisone was associated with a trend toward better survival outcomes in certain patients with chemotherapy-naive metastatic castration-resistant prostate cancer.

A Valentine’s Day Miracle for Cancer Survivors

February 12th 2021

Instead of buying your sweetheart chocolates for Valentine’s Day this year, one cancer survivor suggests people get screened as a gift to their significant other.

Varying Radiation Regimens by Dose, Time Show Similar Long-Term Quality of Life Outcomes in Prostate Cancer

February 3rd 2021

Patients with prostate cancer experienced no significant difference in quality of life when treated with two different types of radiation regimens, recent research has found.

Nubeqa Improves 3-Year Survival in Nonmetastatic Prostate Cancer

January 26th 2021

At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.

Men with Prostate Cancer Experience Higher Levels of Fatigue Due to Inflammation

January 13th 2021

Men who are receiving androgen deprivation therapy treatment for prostate cancer experience higher levels of fatigue and depression when compared to men who are not receiving treatment and who have no history of cancer.

Lynparza Leads to Longer Survival in Men With Prostate Cancer

January 12th 2021

Lynparza demonstrates a significantly longer duration of survival compared Xtandi or Zytiga for men with metastatic prostate cancer, one study found.

Mediterranean Diet Adherence Lowers Disease Progression in Low-Risk Prostate Cancer

January 12th 2021

Researchers observed the benefit of adhering to a Mediterranean diet in all men, in addition to non-White men and those without diabetes.

Talking about Our Family Cancer Risk With My Son

January 9th 2021

Generations of cancer leads to the risk that must be addressed head-on, but the lessons we can take from our own family members who have had cancer is valuable to pass on.

Orgovyx to Treat Advanced Prostate Cancer in Adults Receives FDA Approval

December 18th 2020

Orgovyx is the first oral drug to treat patients with advanced prostate cancer, who were previously treated with intravenous drugs that required clinic visits.

How Theranostics Differs From the Current Prostate Cancer Treatment Options

December 1st 2020

While the current field of prostate cancer research is experiencing an era of “warp speed developments,” perhaps the most exciting option on the horizon is theranostics, according to Dr. Phillip J. Koo.

FDA Approves First PET Imaging Drug for Prostate-Specific Membrane Antigen Positive Lesions in Prostate Cancer

December 1st 2020

The radioactive diagnostic agent, Gallium 68 PSMA-11, can detect suspected prostate cancer metastasis or recurrence, providing another imaging option for these patients.